Pharmacies are fed up with PBMs. Here’s what reforms might be coming
Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...
UBS cuts CVS Health stock price target to $59 from $62
UBS analyst Kevin Caliendo adjusted the price target for CVS Health (NYSE:CVS) shares, bringing it down to $59.00 from the ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...